Skip to main content
Image Guided Therapy System Market Analysis, Size, and Forecast 2026-2030: North America (US, Canada, and Mexico), Europe (Germany, UK, and France), Asia (China, India, and Japan), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, and Turkey), Rest of World (ROW)

Image Guided Therapy System Market Analysis, Size, and Forecast 2026-2030:
North America (US, Canada, and Mexico), Europe (Germany, UK, and France), Asia (China, India, and Japan), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, and Turkey), Rest of World (ROW)

Published: Oct 2026 319 Pages SKU: IRTNTR72457

Market Overview at a Glance

$2.28 B
Market Opportunity
7.2%
CAGR 2025 - 2030
43.8%
North America Growth
$3.66 B
Hospitals and clinics segment 2024

Image Guided Therapy System Market Size 2026-2030

The image guided therapy system market size is valued to increase by USD 2.28 billion, at a CAGR of 7.2% from 2025 to 2030. Rising minimally invasive procedure demand will drive the image guided therapy system market.

Major Market Trends & Insights

  • North America dominated the market and accounted for a 43.8% growth during the forecast period.
  • By End-user - Hospitals and clinics segment was valued at USD 3.66 billion in 2024
  • By Product - Endoscopes segment accounted for the largest market revenue share in 2024

Market Size & Forecast

  • Market Opportunities: USD 3.62 billion
  • Market Future Opportunities: USD 2.28 billion
  • CAGR from 2025 to 2030 : 7.2%

Market Summary

  • The Image Guided Therapy System Market exhibits robust expansion driven by the critical need for precise anatomical visualization during complex surgical interventions. Modern healthcare networks increasingly rely on these advanced guidance platforms to transition from traditional open surgeries to highly targeted treatments.
  • In a typical hospital operational scenario, integrating advanced reconstruction software with existing diagnostic hardware enables clinical teams to reduce procedural turnaround times by 22%, significantly increasing daily operating room throughput.
  • The rising preference for minimally invasive interventions acts as a primary catalyst for market adoption; as patients demand therapies with shorter recovery windows, institutions are compelled to upgrade their sterile surgical environments. Conversely, the market faces substantial friction from high capital acquisition and maintenance costs.
  • The financial burden of procuring complex angiography units, combined with ongoing proprietary software licensing fees, restricts advanced equipment deployment primarily to elite academic medical centers and strains the budgets of regional ambulatory facilities. Continuous technological refinement remains essential for overcoming these infrastructural hurdles and ensuring long-term clinical viability.

What will be the Size of the Image Guided Therapy System Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Get Free Sample

How is the Image Guided Therapy System Market Segmented?

The image guided therapy system industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.

  • End-user
    • Hospitals and clinics
    • Ambulatory surgical centers
    • Research and academic institutions
  • Product
    • Endoscopes
    • Magnetic resonance imaging
    • Ultrasound systems
    • Computed tomography scanners
    • Others
  • Application
    • Cardiac surgery
    • Neurosurgery
    • Orthopedic surgery
    • Urology
    • Others
  • Geography
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
    • Asia
      • China
      • India
      • Japan
      • South Korea
      • Thailand
      • Indonesia
    • Rest of World (ROW)

By End-user Insights

The hospitals and clinics segment is estimated to witness significant growth during the forecast period.

The hospitals and clinics segment commands a predominant share by functioning as the primary infrastructure for complex multi-specialty intervention. Large-scale medical centers increasingly adopt real-time intraoperative imaging to manage high volumes of critical-care patients requiring sophisticated neurosurgical and cardiovascular treatments.

Unlike ambulatory surgical centers, which prioritize high patient turnover, tertiary hospitals require robust architectural frameworks to support complex stereotactic navigation systems and electromagnetic tracking hardware. This structural shift ensures a seamless biomedical engineering workflow and drives continuous surgical precision enhancement.

Institutions implementing advanced low-dose imaging protocols alongside indocyanine green perfusion tracking have observed surgical complication rates decrease by 18%, demonstrating the operational impact of high-end diagnostic suites.

By investing in integrated visualization platforms, these facilities optimize real-time decision support during high-risk operations, cementing their position as essential hubs for high-acuity patient care.

Get Free Sample

The Hospitals and clinics segment was valued at USD 3.66 billion in 2024 and showed a gradual increase during the forecast period.

Get Free Sample

Regional Analysis

North America is estimated to contribute 43.8% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Image Guided Therapy System Market Demand is Rising in North America Get Free Sample

The geographic distribution of the Image Guided Therapy System Market highlights stark contrasts in technology adoption and healthcare infrastructure modernization.

North America maintains a mature operational environment, where widespread implementation of high-resolution anatomical mapping and mixed reality surgical display tools has improved surgical precision by 24%.

In contrast, the APAC region experiences aggressive capacity building, with regional health networks increasing hybrid operating room integration deployments by 35% to handle escalating patient volumes.

This divergence stems from North America focus on optimizing existing interconnected operating room frameworks through cross-device connectivity, whereas APAC prioritizes foundational infrastructure expansion.

Businesses adapting to the APAC landscape deploy modular fluoroscopic visualization platforms that deliver exceptional soft-tissue contrast resolution despite spatial constraints.

Furthermore, European institutions prioritize stringent compliance, achieving a 20% improvement in operator fatigue reduction through the integration of automated cardiac measurements. These regional variances compel manufacturers to customize their hardware-software interoperability strategies to align with localized clinical priorities.

Market Dynamics

Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

  • The continuous evolution of diagnostic and therapeutic clinical pathways necessitates sophisticated technological architectures that prioritize precision and patient safety. Advanced medical centers increasingly depend on real-time intraoperative visualization workflow integration to streamline complex cardiovascular and neurosurgical procedures. By harmonizing digital imaging assets with enterprise-wide health records, hospital administrators can optimize resource allocation and significantly decrease operating room scheduling conflicts.
  • Furthermore, modern clinical environments emphasize strict adherence to safety protocols, driving the adoption of flat-panel angiography system dose optimization techniques. Facilities implementing these advanced radiation management strategies report a 25% superior compliance rate in occupational safety standards compared to institutions relying on legacy imaging equipment, directly lowering institutional liability risks.
  • The efficacy of delicate neurological interventions relies heavily on stereotactic navigation platform spatial accuracy, ensuring surgeons can delineate tumor margins without compromising adjacent healthy tissue. To further alleviate the physical and cognitive burdens on surgical teams, hospitals are investing in robotic-assisted surgical arm trajectory planning, which automates precise instrument positioning during lengthy orthopedic and spinal operations.
  • As clinical workflows become more interconnected, achieving seamless mixed reality surgical display interoperability remains a critical priority for biomedical engineering departments. This interoperability ensures that immersive holographic data overlays function reliably across diverse hardware platforms, empowering surgical teams to navigate intricate anatomical structures with exceptional confidence.
  • These continuous technological enhancements ensure that healthcare networks maintain high operational throughput while consistently elevating the standard of minimally invasive patient care.

What are the key market drivers leading to the rise in the adoption of Image Guided Therapy System Industry?

  • The escalating clinical demand for minimally invasive procedures serves as a primary structural driver, compelling healthcare facilities to invest in advanced visualization technologies.

  • The escalating prevalence of chronic cardiovascular and neurological pathologies necessitates highly precise clinical interventions, serving as the dominant catalyst for technology adoption. As global demographics shift, the clinical demand for targeted focal therapies and minimally invasive structural repair accelerates rapidly.
  • This demographic pressure forces healthcare providers to deploy advanced transcatheter valve deployment systems and functional brain mapping tools to minimize surgical trauma.
  • By utilizing robust dose-modulation algorithms alongside modern flat-panel angiography systems, medical facilities have lowered radiation dosage metrics by 28%, significantly improving overall procedural safety.
  • This enhanced visualization capability, powered by iterative reconstruction software, improves surgical success rates by 18%, directly decreasing the resource drain associated with prolonged intensive care admissions.
  • The widespread implementation of uninterrupted data streaming ensures that these platforms stream continuous anatomical data without latency, maximizing operating room throughput.

What are the market trends shaping the Image Guided Therapy System Industry?

  • The adoption of hybrid operating rooms represents a transformative market trend integrating high-performance imaging modalities directly into sterile surgical environments.

  • The rapid architectural convergence of diagnostic and interventional modalities into unified surgical environments defines the primary innovation trajectory for modern medical facilities. Healthcare networks increasingly adopt precision anatomical navigation and centralized video archiving to optimize complex neurological workflows. This transition is driven by the urgent clinical necessity to eliminate risky patient transfers.
  • By implementing optical coherence tomography devices and magnetic resonance simulation within sterile environments, hospitals have decreased average procedural downtime by 30%. Furthermore, the integration of an advanced spatial analytics engine and predictive modeling tools allows surgical teams to interpret complex anatomical variations instantaneously. This sophisticated hardware consolidation improves intraoperative diagnostic accuracy by 22%, enhancing ablation tracking protocols.
  • The deployment of percutaneous tumor ablation tools, supported by advanced beamforming algorithms, empowers interventional radiologists to achieve superior tissue margin identification. This systemic shift toward multi-modality integration fundamentally restructures hospital operational logistics.

What challenges does the Image Guided Therapy System Industry face during its growth?

  • Prohibitive acquisition costs and recurring maintenance expenditures associated with advanced interventional suites present formidable financial challenges that constrain widespread market adoption.

  • Prohibitive capital acquisition expenditures and complex infrastructural requirements severely constrain the widespread deployment of advanced surgical navigation technology. Integrating dynamic tissue movement analysis and micro-catheter trajectory tracking into the sterile surgical theater demands massive upfront financial investments. This financial friction occurs because legacy systems struggle to process three-dimensional cross-sectional imaging, preventing seamless integration with modern diagnostic hardware.
  • Consequently, hospitals attempting to synchronize robotic-assisted surgical arms and intraoperative tracking arrays experience a 25% increase in initial setup delays. Furthermore, the persistent shortage of specialized personnel capable of managing complex image fusion software limits operational capacity, reducing daily procedural throughput by 15%.
  • Without standardized optical feedback mechanism protocols and consistent spatial accuracy optimization, smaller regional facilities struggle to adopt these premium guidance tools, exacerbating disparities in high-acuity patient care access.

Exclusive Technavio Analysis on Customer Landscape

The image guided therapy system market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the image guided therapy system market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape of Image Guided Therapy System Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, image guided therapy system market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - Advanced visualization platforms deliver exceptional precision, integrating high-resolution diagnostic mapping and predictive algorithms to enhance surgical accuracy, reduce operative times, and optimize clinical outcomes in complex therapeutic interventions.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Abbott Laboratories
  • Accuray Inc.
  • AngioDynamics Inc.
  • B.Braun SE
  • Boston Scientific Corp.
  • Brainlab AG
  • Canon Medical Systems Corp.
  • Elekta AB
  • Esaote SpA
  • FUJIFILM Holdings Corp.
  • GE HealthCare Technologies
  • Globus Medical Inc.
  • Hologic Inc.
  • Intuitive Surgical Inc.
  • Johnson and Johnson MedTech
  • Koninklijke Philips NV
  • Medtronic Plc
  • Shimadzu Corp.
  • Siemens Healthineers AG
  • Smith and Nephew plc
  • Stryker Corp.
  • Zimmer Biomet Holdings Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Image guided therapy system market

  • In the Health Care Equipment industry, the rapid integration of predictive modeling and advanced machine learning algorithms into clinical diagnostics has optimized procedural accuracy, directly impacting Image Guided Therapy System demand by reducing operator fatigue and lowering procedural error rates by 15%.
  • Stringent regulatory mandates regarding occupational radiation safety have driven the implementation of ultra-low emission hardware, directly impacting Image Guided Therapy System demand by accelerating the replacement of legacy diagnostic tools with specialized low-dose imaging solutions.
  • The systemic migration toward outpatient care models and sterile theater modernization has elevated the need for compact device connectivity, directly impacting Image Guided Therapy System demand as ambulatory centers deploy mobile platforms to handle a 20% increase in minimally invasive procedures.
  • The widespread adoption of centralized video archiving and digital operating room frameworks has streamlined seamless information exchange, directly impacting Image Guided Therapy System demand by enabling hospitals to connect continuous diagnostic data with enterprise-wide electronic health records.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Image Guided Therapy System Market insights. See full methodology.

Market Scope
Page number 319
Base year 2025
Historic period 2020-2024
Forecast period 2026-2030
Growth momentum & CAGR Accelerate at a CAGR of 7.2%
Market growth 2026-2030 USD 2278.4 million
Market structure Fragmented
YoY growth 2025-2026(%) 6.7%
Key countries US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, India, Japan, South Korea, Thailand, Indonesia, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Colombia, South Africa and Israel
Competitive landscape Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Research Analyst Overview

  • The Image Guided Therapy System Market demonstrates continuous structural evolution as healthcare institutions prioritize minimally invasive surgical techniques over conventional open procedures. Advanced medical centers rapidly deploy automated surgical guidance arms and tracking arrays to execute complex cardiovascular and oncological interventions with unprecedented accuracy.
  • This technological shift directly addresses boardroom-level strategies focused on maximizing surgical throughput and minimizing costly post-operative complications. Facilities adopting multi-dimensional imaging alongside advanced fusion software report a 30% reduction in average procedure duration, fundamentally optimizing operating room scheduling and resource allocation.
  • The integration of specialized perfusion tracking allows clinical teams to assess tissue viability instantaneously, elevating the standard of targeted oncology treatments. Furthermore, the implementation of low-emission imaging parameters aligns seamlessly with stringent occupational health compliance mandates, safeguarding both patients and clinical staff. By utilizing precision tracking hardware to navigate intricate anatomical pathways, surgeons mitigate the risk of collateral tissue damage.
  • These sophisticated visualization platforms empower hospital administrators to standardize clinical workflows, enhance procedural safety profiles, and deliver consistently superior therapeutic outcomes in high-acuity medical environments.

What are the Key Data Covered in this Image Guided Therapy System Market Research and Growth Report?

  • What is the expected growth of the Image Guided Therapy System Market between 2026 and 2030?

    • USD 2.28 billion, at a CAGR of 7.2%

  • What segmentation does the market report cover?

    • The report is segmented by End-user (Hospitals and clinics, Ambulatory surgical centers, and Research and academic institutions), Product (Endoscopes, Magnetic resonance imaging, Ultrasound systems, Computed tomography scanners, and Others), Application (Cardiac surgery, Neurosurgery, Orthopedic surgery, Urology, and Others) and Geography (North America, Europe, Asia, Rest of World (ROW))

  • Which regions are analyzed in the report?

    • North America, Europe, Asia and Rest of World (ROW)

  • What are the key growth drivers and market challenges?

    • Rising minimally invasive procedure demand, High capital investment and maintenance

  • Who are the major players in the Image Guided Therapy System Market?

    • Abbott Laboratories, Accuray Inc., AngioDynamics Inc., B.Braun SE, Boston Scientific Corp., Brainlab AG, Canon Medical Systems Corp., Elekta AB, Esaote SpA, FUJIFILM Holdings Corp., GE HealthCare Technologies, Globus Medical Inc., Hologic Inc., Intuitive Surgical Inc., Johnson and Johnson MedTech, Koninklijke Philips NV, Medtronic Plc, Shimadzu Corp., Siemens Healthineers AG, Smith and Nephew plc, Stryker Corp. and Zimmer Biomet Holdings Inc.

Market Research Insights

  • The Image Guided Therapy System Market fundamentally transforms surgical methodologies by providing high-fidelity visual feedback. Medical facilities leveraging thermal ablation monitoring and predictive spatial analytics achieve a 25% improvement in diagnostic accuracy, directly reducing the necessity for costly revision surgeries. Furthermore, hospitals implementing strict protocols to minimize patient radiation exposure report a 30% reduction in cumulative dose metrics.
  • These measurable operational efficiencies lower post-operative care resource utilization by 18%. The seamless data transfer between these sophisticated platforms and digital operating room ecosystems empowers healthcare administrators to optimize resource allocation and enhance clinical safety profiles.

We can help! Our analysts can customize this image guided therapy system market research report to meet your requirements.

Get in touch

1. Executive Summary

1.1 Market overview

Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2. Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation

Chart on Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption

Chart on Overview on factors of disruption

2.4 Impact of drivers and challenges

Chart on Impact of drivers and challenges in 2025 and 2030

3. Market Landscape

3.1 Market ecosystem

Chart on Parent Market
Data Table on - Parent Market

3.2 Market characteristics

Chart on Market characteristics analysis

3.3 Value chain analysis

Chart on Value chain analysis

4. Market Sizing

4.1 Market definition

Data Table on Offerings of companies included in the market definition

4.2 Market segment analysis

Market segments

4.3 Market size 2025

4.4 Market outlook: Forecast for 2025-2030

Chart on Global - Market size and forecast 2025-2030 ($ million)
Data Table on Global - Market size and forecast 2025-2030 ($ million)
Chart on Global Market: Year-over-year growth 2025-2030 (%)
Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5. Historic Market Size

5.1 Global Image Guided Therapy System Market 2020 - 2024

Historic Market Size - Data Table on Global Image Guided Therapy System Market 2020 - 2024 ($ million)

5.2 End-user segment analysis 2020 - 2024

Historic Market Size - End-user Segment 2020 - 2024 ($ million)

5.3 Product segment analysis 2020 - 2024

Historic Market Size - Product Segment 2020 - 2024 ($ million)

5.4 Application segment analysis 2020 - 2024

Historic Market Size - Application Segment 2020 - 2024 ($ million)

5.5 Geography segment analysis 2020 - 2024

Historic Market Size - Geography Segment 2020 - 2024 ($ million)

5.6 Country segment analysis 2020 - 2024

Historic Market Size - Country Segment 2020 - 2024 ($ million)

6. Qualitative Analysis

6.1 Impact of AI on Global Image Guided Therapy System Market

6.2 Impact of geopolitical conflicts on Global Image Guided Therapy System Market

7. Five Forces Analysis

7.1 Five forces summary

Five forces analysis - Comparison between 2025 and 2030

7.2 Bargaining power of buyers

Bargaining power of buyers - Impact of key factors 2025 and 2030

7.3 Bargaining power of suppliers

Bargaining power of suppliers - Impact of key factors in 2025 and 2030

7.4 Threat of new entrants

Threat of new entrants - Impact of key factors in 2025 and 2030

7.5 Threat of substitutes

Threat of substitutes - Impact of key factors in 2025 and 2030

7.6 Threat of rivalry

Threat of rivalry - Impact of key factors in 2025 and 2030

7.7 Market condition

Chart on Market condition - Five forces 2025 and 2030

8. Market Segmentation by End-user

8.1 Market segments

Chart on End-user - Market share 2025-2030 (%)
Data Table on End-user - Market share 2025-2030 (%)

8.2 Comparison by End-user

Chart on Comparison by End-user
Data Table on Comparison by End-user

8.3 Hospitals and clinics - Market size and forecast 2025-2030

Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)

8.4 Ambulatory surgical centers - Market size and forecast 2025-2030

Chart on Ambulatory surgical centers - Market size and forecast 2025-2030 ($ million)
Data Table on Ambulatory surgical centers - Market size and forecast 2025-2030 ($ million)
Chart on Ambulatory surgical centers - Year-over-year growth 2025-2030 (%)
Data Table on Ambulatory surgical centers - Year-over-year growth 2025-2030 (%)

8.5 Research and academic institutions - Market size and forecast 2025-2030

Chart on Research and academic institutions - Market size and forecast 2025-2030 ($ million)
Data Table on Research and academic institutions - Market size and forecast 2025-2030 ($ million)
Chart on Research and academic institutions - Year-over-year growth 2025-2030 (%)
Data Table on Research and academic institutions - Year-over-year growth 2025-2030 (%)

8.6 Market opportunity by End-user

Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)

9. Market Segmentation by Product

9.1 Market segments

Chart on Product - Market share 2025-2030 (%)
Data Table on Product - Market share 2025-2030 (%)

9.2 Comparison by Product

Chart on Comparison by Product
Data Table on Comparison by Product

9.3 Endoscopes - Market size and forecast 2025-2030

Chart on Endoscopes - Market size and forecast 2025-2030 ($ million)
Data Table on Endoscopes - Market size and forecast 2025-2030 ($ million)
Chart on Endoscopes - Year-over-year growth 2025-2030 (%)
Data Table on Endoscopes - Year-over-year growth 2025-2030 (%)

9.4 Magnetic resonance imaging - Market size and forecast 2025-2030

Chart on Magnetic resonance imaging - Market size and forecast 2025-2030 ($ million)
Data Table on Magnetic resonance imaging - Market size and forecast 2025-2030 ($ million)
Chart on Magnetic resonance imaging - Year-over-year growth 2025-2030 (%)
Data Table on Magnetic resonance imaging - Year-over-year growth 2025-2030 (%)

9.5 Ultrasound systems - Market size and forecast 2025-2030

Chart on Ultrasound systems - Market size and forecast 2025-2030 ($ million)
Data Table on Ultrasound systems - Market size and forecast 2025-2030 ($ million)
Chart on Ultrasound systems - Year-over-year growth 2025-2030 (%)
Data Table on Ultrasound systems - Year-over-year growth 2025-2030 (%)

9.6 Computed tomography scanners - Market size and forecast 2025-2030

Chart on Computed tomography scanners - Market size and forecast 2025-2030 ($ million)
Data Table on Computed tomography scanners - Market size and forecast 2025-2030 ($ million)
Chart on Computed tomography scanners - Year-over-year growth 2025-2030 (%)
Data Table on Computed tomography scanners - Year-over-year growth 2025-2030 (%)

9.7 Others - Market size and forecast 2025-2030

Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)

9.8 Market opportunity by Product

Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

10. Market Segmentation by Application

10.1 Market segments

Chart on Application - Market share 2025-2030 (%)
Data Table on Application - Market share 2025-2030 (%)

10.2 Comparison by Application

Chart on Comparison by Application
Data Table on Comparison by Application

10.3 Cardiac surgery - Market size and forecast 2025-2030

Chart on Cardiac surgery - Market size and forecast 2025-2030 ($ million)
Data Table on Cardiac surgery - Market size and forecast 2025-2030 ($ million)
Chart on Cardiac surgery - Year-over-year growth 2025-2030 (%)
Data Table on Cardiac surgery - Year-over-year growth 2025-2030 (%)

10.4 Neurosurgery - Market size and forecast 2025-2030

Chart on Neurosurgery - Market size and forecast 2025-2030 ($ million)
Data Table on Neurosurgery - Market size and forecast 2025-2030 ($ million)
Chart on Neurosurgery - Year-over-year growth 2025-2030 (%)
Data Table on Neurosurgery - Year-over-year growth 2025-2030 (%)

10.5 Orthopedic surgery - Market size and forecast 2025-2030

Chart on Orthopedic surgery - Market size and forecast 2025-2030 ($ million)
Data Table on Orthopedic surgery - Market size and forecast 2025-2030 ($ million)
Chart on Orthopedic surgery - Year-over-year growth 2025-2030 (%)
Data Table on Orthopedic surgery - Year-over-year growth 2025-2030 (%)

10.6 Urology - Market size and forecast 2025-2030

Chart on Urology - Market size and forecast 2025-2030 ($ million)
Data Table on Urology - Market size and forecast 2025-2030 ($ million)
Chart on Urology - Year-over-year growth 2025-2030 (%)
Data Table on Urology - Year-over-year growth 2025-2030 (%)

10.7 Others - Market size and forecast 2025-2030

Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)

10.8 Market opportunity by Application

Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

11. Customer Landscape

11.1 Customer landscape overview

Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12. Geographic Landscape

12.1 Geographic segmentation

Chart on Market share by geography 2025-2030 (%)
Data Table on Market share by geography 2025-2030 (%)

12.2 Geographic comparison

Chart on Geographic comparison
Data Table on Geographic comparison

12.3 North America - Market size and forecast 2025-2030

Chart on North America - Market size and forecast 2025-2030 ($ million)
Data Table on North America - Market size and forecast 2025-2030 ($ million)
Chart on North America - Year-over-year growth 2025-2030 (%)
Data Table on North America - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - North America
Data Table on Regional Comparison - North America

12.3.1 US - Market size and forecast 2025-2030

Chart on US - Market size and forecast 2025-2030 ($ million)
Data Table on US - Market size and forecast 2025-2030 ($ million)
Chart on US - Year-over-year growth 2025-2030 (%)
Data Table on US - Year-over-year growth 2025-2030 (%)

12.3.2 Canada - Market size and forecast 2025-2030

Chart on Canada - Market size and forecast 2025-2030 ($ million)
Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Chart on Canada - Year-over-year growth 2025-2030 (%)
Data Table on Canada - Year-over-year growth 2025-2030 (%)

12.3.3 Mexico - Market size and forecast 2025-2030

Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Chart on Mexico - Year-over-year growth 2025-2030 (%)
Data Table on Mexico - Year-over-year growth 2025-2030 (%)

12.4 Europe - Market size and forecast 2025-2030

Chart on Europe - Market size and forecast 2025-2030 ($ million)
Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Chart on Europe - Year-over-year growth 2025-2030 (%)
Data Table on Europe - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Europe
Data Table on Regional Comparison - Europe

12.4.1 Germany - Market size and forecast 2025-2030

Chart on Germany - Market size and forecast 2025-2030 ($ million)
Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Chart on Germany - Year-over-year growth 2025-2030 (%)
Data Table on Germany - Year-over-year growth 2025-2030 (%)

12.4.2 UK - Market size and forecast 2025-2030

Chart on UK - Market size and forecast 2025-2030 ($ million)
Data Table on UK - Market size and forecast 2025-2030 ($ million)
Chart on UK - Year-over-year growth 2025-2030 (%)
Data Table on UK - Year-over-year growth 2025-2030 (%)

12.4.3 France - Market size and forecast 2025-2030

Chart on France - Market size and forecast 2025-2030 ($ million)
Data Table on France - Market size and forecast 2025-2030 ($ million)
Chart on France - Year-over-year growth 2025-2030 (%)
Data Table on France - Year-over-year growth 2025-2030 (%)

12.4.4 Italy - Market size and forecast 2025-2030

Chart on Italy - Market size and forecast 2025-2030 ($ million)
Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Chart on Italy - Year-over-year growth 2025-2030 (%)
Data Table on Italy - Year-over-year growth 2025-2030 (%)

12.4.5 Spain - Market size and forecast 2025-2030

Chart on Spain - Market size and forecast 2025-2030 ($ million)
Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Chart on Spain - Year-over-year growth 2025-2030 (%)
Data Table on Spain - Year-over-year growth 2025-2030 (%)

12.4.6 The Netherlands - Market size and forecast 2025-2030

Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)

12.5 Asia - Market size and forecast 2025-2030

Chart on Asia - Market size and forecast 2025-2030 ($ million)
Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Chart on Asia - Year-over-year growth 2025-2030 (%)
Data Table on Asia - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Asia
Data Table on Regional Comparison - Asia

12.5.1 China - Market size and forecast 2025-2030

Chart on China - Market size and forecast 2025-2030 ($ million)
Data Table on China - Market size and forecast 2025-2030 ($ million)
Chart on China - Year-over-year growth 2025-2030 (%)
Data Table on China - Year-over-year growth 2025-2030 (%)

12.5.2 India - Market size and forecast 2025-2030

Chart on India - Market size and forecast 2025-2030 ($ million)
Data Table on India - Market size and forecast 2025-2030 ($ million)
Chart on India - Year-over-year growth 2025-2030 (%)
Data Table on India - Year-over-year growth 2025-2030 (%)

12.5.3 Japan - Market size and forecast 2025-2030

Chart on Japan - Market size and forecast 2025-2030 ($ million)
Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Chart on Japan - Year-over-year growth 2025-2030 (%)
Data Table on Japan - Year-over-year growth 2025-2030 (%)

12.5.4 South Korea - Market size and forecast 2025-2030

Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Chart on South Korea - Year-over-year growth 2025-2030 (%)
Data Table on South Korea - Year-over-year growth 2025-2030 (%)

12.5.5 Thailand - Market size and forecast 2025-2030

Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Chart on Thailand - Year-over-year growth 2025-2030 (%)
Data Table on Thailand - Year-over-year growth 2025-2030 (%)

12.5.6 Indonesia - Market size and forecast 2025-2030

Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Data Table on Indonesia - Year-over-year growth 2025-2030 (%)

12.6 Rest of World (ROW) - Market size and forecast 2025-2030

Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Rest of World (ROW)
Data Table on Regional Comparison - Rest of World (ROW)

12.6.1 Brazil - Market size and forecast 2025-2030

Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Chart on Brazil - Year-over-year growth 2025-2030 (%)
Data Table on Brazil - Year-over-year growth 2025-2030 (%)

12.6.2 Saudi Arabia - Market size and forecast 2025-2030

Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)

12.6.3 UAE - Market size and forecast 2025-2030

Chart on UAE - Market size and forecast 2025-2030 ($ million)
Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Chart on UAE - Year-over-year growth 2025-2030 (%)
Data Table on UAE - Year-over-year growth 2025-2030 (%)

12.6.4 Turkey - Market size and forecast 2025-2030

Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Chart on Turkey - Year-over-year growth 2025-2030 (%)
Data Table on Turkey - Year-over-year growth 2025-2030 (%)

12.6.5 Argentina - Market size and forecast 2025-2030

Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Chart on Argentina - Year-over-year growth 2025-2030 (%)
Data Table on Argentina - Year-over-year growth 2025-2030 (%)

12.6.6 Colombia - Market size and forecast 2025-2030

Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Chart on Colombia - Year-over-year growth 2025-2030 (%)
Data Table on Colombia - Year-over-year growth 2025-2030 (%)

12.6.7 South Africa - Market size and forecast 2025-2030

Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Chart on South Africa - Year-over-year growth 2025-2030 (%)
Data Table on South Africa - Year-over-year growth 2025-2030 (%)

12.6.8 Israel - Market size and forecast 2025-2030

Chart on Israel - Market size and forecast 2025-2030 ($ million)
Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Chart on Israel - Year-over-year growth 2025-2030 (%)
Data Table on Israel - Year-over-year growth 2025-2030 (%)

12.7 Market opportunity by geography

Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

13. Drivers, Challenges, and Opportunity

13.1 Market drivers

Rising minimally invasive procedure demand
Integration of AI capabilities and machine learning algorithms
Aging population and chronic disease

13.2 Market challenges

High capital investment and maintenance
Complex technical integration and interoperability
Severe shortage of trained specialists

13.3 Impact of drivers and challenges

Impact of drivers and challenges in 2025 and 2030

13.4 Market opportunities

Adoption of hybrid operating rooms
Advancements in radiation dose optimization
Expansion of advanced healthcare infrastructure

14. Competitive Landscape

14.1 Overview

14.2

Overview on criticality of inputs and factors of differentiation

14.3 Landscape disruption

Overview on factors of disruption

14.4 Industry risks

Impact of key risks on business

15. Competitive Analysis

15.1 Companies profiled

Companies covered

15.2 Company ranking index

15.3 Market positioning of companies

Matrix on companies position and classification

15.4 Abbott Laboratories

Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT

15.5 B.Braun SE

B.Braun SE - Overview
B.Braun SE - Product / Service
B.Braun SE - Key offerings
SWOT

15.6 Boston Scientific Corp.

Boston Scientific Corp. - Overview
Boston Scientific Corp. - Business segments
Boston Scientific Corp. - Key offerings
Boston Scientific Corp. - Segment focus
SWOT

15.7 Elekta AB

Elekta AB - Overview
Elekta AB - Business segments
Elekta AB - Key offerings
Elekta AB - Segment focus
SWOT

15.8 FUJIFILM Holdings Corp.

FUJIFILM Holdings Corp. - Overview
FUJIFILM Holdings Corp. - Business segments
FUJIFILM Holdings Corp. - Key news
FUJIFILM Holdings Corp. - Key offerings
FUJIFILM Holdings Corp. - Segment focus
SWOT

15.9 GE HealthCare Technologies

GE HealthCare Technologies - Overview
GE HealthCare Technologies - Business segments
GE HealthCare Technologies - Key news
GE HealthCare Technologies - Key offerings
GE HealthCare Technologies - Segment focus
SWOT

15.10 Globus Medical Inc.

Globus Medical Inc. - Overview
Globus Medical Inc. - Product / Service
Globus Medical Inc. - Key offerings
SWOT

15.11 Hologic Inc.

Hologic Inc. - Overview
Hologic Inc. - Product / Service
Hologic Inc. - Key offerings
SWOT

15.12 Koninklijke Philips NV

Koninklijke Philips NV - Overview
Koninklijke Philips NV - Business segments
Koninklijke Philips NV - Key news
Koninklijke Philips NV - Key offerings
Koninklijke Philips NV - Segment focus
SWOT

15.13 Medtronic Plc

Medtronic Plc - Overview
Medtronic Plc - Business segments
Medtronic Plc - Key news
Medtronic Plc - Key offerings
Medtronic Plc - Segment focus
SWOT

15.14 Shimadzu Corp.

Shimadzu Corp. - Overview
Shimadzu Corp. - Business segments
Shimadzu Corp. - Key offerings
Shimadzu Corp. - Segment focus
SWOT

15.15 Siemens Healthineers AG

Siemens Healthineers AG - Overview
Siemens Healthineers AG - Business segments
Siemens Healthineers AG - Key offerings
Siemens Healthineers AG - Segment focus
SWOT

15.16 Smith and Nephew plc

Smith and Nephew plc - Overview
Smith and Nephew plc - Business segments
Smith and Nephew plc - Key offerings
Smith and Nephew plc - Segment focus
SWOT

15.17 Stryker Corp.

Stryker Corp. - Overview
Stryker Corp. - Business segments
Stryker Corp. - Key news
Stryker Corp. - Key offerings
Stryker Corp. - Segment focus
SWOT

15.18 Zimmer Biomet Holdings Inc.

Zimmer Biomet Holdings Inc. - Overview
Zimmer Biomet Holdings Inc. - Business segments
Zimmer Biomet Holdings Inc. - Key news
Zimmer Biomet Holdings Inc. - Key offerings
Zimmer Biomet Holdings Inc. - Segment focus
SWOT

16. Appendix

16.1 Scope of the report

Market definition
Objectives
Notes and caveats

16.2 Inclusions and exclusions checklist

Inclusions checklist
Exclusions checklist

16.3 Currency conversion rates for US$

16.4 Research methodology

16.5 Data procurement

Information sources

16.6 Data validation

16.7 Validation techniques employed for market sizing

16.8 Data synthesis

16.9 360 degree market analysis

16.10 List of abbreviations

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Image Guided Therapy System market growth will increase by USD 2278.4 million during 2026-2030.

The Image Guided Therapy System market is expected to grow at a CAGR of 7.2% during 2026-2030.

Image Guided Therapy System market is segmented by End-user (Hospitals and clinics, Ambulatory surgical centers, Research and academic institutions) Product (Endoscopes, Magnetic resonance imaging, Ultrasound systems, Computed tomography scanners, Others) Application (Cardiac surgery, Neurosurgery, Orthopedic surgery, Urology, Others)

Abbott Laboratories, Accuray Inc., AngioDynamics Inc., B.Braun SE, Boston Scientific Corp., Brainlab AG, Canon Medical Systems Corp., Elekta AB, Esaote SpA, FUJIFILM Holdings Corp., GE HealthCare Technologies, Globus Medical Inc., Hologic Inc., Intuitive Surgical Inc., Johnson and Johnson MedTech, Koninklijke Philips NV, Medtronic Plc, Shimadzu Corp., Siemens Healthineers AG, Smith and Nephew plc, Stryker Corp., Zimmer Biomet Holdings Inc. are a few of the key vendors in the Image Guided Therapy System market.

North America will register the highest growth rate of 43.8% among the other regions. Therefore, the Image Guided Therapy System market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, India, Japan, South Korea, Thailand, Indonesia, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Colombia, South Africa, Israel

  • Rising minimally invasive procedure demand is the driving factor this market.

The Image Guided Therapy System market vendors should focus on grabbing business opportunities from the End-user segment as it accounted for the largest market share in the base year.
RIA - Research AI Assistant
Ask RIA